6
Disclosures
Jan 23, 2026 — Feb 26, 2026
Date Range
PRIME
Market Segment
Pharmaceutical
Sector
Disclosures
| Date | Type | Headline | |
|---|---|---|---|
| Feb 26 | Personnel | JCR Pharmaceuticals Co.,Ltd. Announces Board Responsibility Changes | |
| Jan 28 | Earnings | JCR Pharmaceuticals Co., Ltd. Q3 FY2026 Earnings Presentation: Revenue of 30.4 billion, +17.3% YoY | |
| Jan 28 | Earnings | JCR Pharma Reports Special Gain of 1.4 Billion in Q3 | |
| Jan 28 | Earnings | JCR Pharmaceuticals Co., Ltd. Q3 FY2026 Earnings Presentation: Revenue of 25.9 billion, +17.3% YoY | |
| Jan 28 | Forecast | FY2026/3 Full-Year Earnings Forecast Revision | |
| Jan 23 | Other | JCR Pharmaceuticals Enters Exclusive Licensing Deal with Italfarmaco for Givinostat |
Disclosure Types
Earnings: 3 Personnel: 1 Forecast: 1 Other: 1